Primary Immunodeficiency Disease News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

FDA OKs Immunoglobulin Xembify for Primary Immunodeficiencies FDA OKs Immunoglobulin Xembify for Primary Immunodeficiencies
Xembify is a 20% immune globulin solution for subcutaneous injection indicated to treat primary immunodeficiencies in patients aged 2 years and older.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 6, 2019 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news

FDA Approves Xembify (immune globulin subcutaneous) for Primary Immunodeficiencies
Barcelona, July 4, 2019.- Grifols, a leading global producer of plasma-derived medicines, announced today that Xembify, its new 20% subcutaneous immunoglobulin, has been approved by the U.S. Food and Drug Administration (FDA). Xembify is used to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 4, 2019 Category: Drugs & Pharmacology Source Type: news

Does She Have SCID?
Discussion Severe-combined immunodefiency (SCID) is actually a group of inherited disorders with an absence or dysfunction of T, B and NK cells that results in severe dysfunction of the immune system. SCID is a primary immunodeficiency. SCID was thought to be a rare disorder but with the advent of neonatal screening the incidence in the US general population is estimated at ~1 in 58,000 live births, but with numbers higher or lower depending on the specific population. Patients often have failure to thrive, oral candidiasis, and diarrhea as infants as well as a variety of infectious diseases. They can also have interstit...
Source: PediatricEducation.org - December 3, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Tandem Lung-Bone Marrow Transplant Shows Promise
(MedPage Today) -- Protocol being used in patients with primary immunodeficiencies (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 9, 2018 Category: Respiratory Medicine Source Type: news

Cancer Rates Raised in Patients With Primary Immunodeficiency Diseases
Patients with primary immunodeficiency diseases are at increased risk of certain cancers, according to a new study. The strongest association was with lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - August 3, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Leukemia & Lymphoma News Source Type: news

Celebrating 10 years of success for Infusion
As the business took off, more space was needed, and the company moved in 2009 to “real” office space just up the road in Haddam, CT, across the street from the Connecticut River, eventually employing a staff of 10 that year. A year later, in 2010, Infusion had doubled in size and became part of the UDG/Ashfield family. Infusion continued to grow at a steady pace into new therapeutic areas with more clients and employees, and in October 2016, Infusion left its country setting and moved into larger corporate offices in downtown Middletown, CT. Our staff now comprises 45 people and includes account executives, medical wr...
Source: Ashfield Healthcare News - July 11, 2017 Category: Pharmaceuticals Authors: Sarah Edwards Tags: Ashfield Source Type: news

5 Surprising Things You Didn’t Know About Your Immune System
People often make reference to the immune system when feeling under the weather, but we wondered how many people truly understand the complexities of this internal task force? To put it plainly, the immune system is a network of cells, tissues and organs that work together to protect the body. It is the immune system’s responsibility to tell your body what belongs and what does not. In rare chronic cases, like primary immunodeficiency, the immune system is either missing or isn’t working properly, but for most healthy people, it separates friend from foe ― and responds to enemies (like bacteria, viruses and ...
Source: Healthy Living - The Huffington Post - April 27, 2017 Category: Consumer Health News Source Type: news

Novel Tools for Primary Immunodeficiency Diagnosis Novel Tools for Primary Immunodeficiency Diagnosis
Explore novel deep profiling approaches for the diagnosis and assessment of primary immunodeficiencies.Current Opinion in Allergy and Clinical Immunology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 6, 2017 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Journal Article Source Type: news

Genes Associated With Common Variable Immunodeficiency Genes Associated With Common Variable Immunodeficiency
This review summarizes current knowledge regarding the molecular genetic basis of common variable immunodeficiency, one of the most prevalent primary immunodeficiencies.Journal of Medical Genetics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 16, 2016 Category: Allergy & Immunology Tags: Pathology & Lab Medicine Journal Article Source Type: news

Rubella virus persists after vaccination in some patients with immunodeficiency disorders
Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine. Although the vaccine for rubella (German measles) has an established record of safety and effectiveness in the general population, patients with severe deficiencies in their immune defenses may be susceptible to side effects from the vaccine, say researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 4, 2016 Category: Science Source Type: news

Rubella virus persists after vaccination in some patients with rare immune disorders
(Children's Hospital of Philadelphia) Some patients with rare primary immunodeficiency disorders may at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine. Although the vaccine for rubella (German measles) has an established record of safety and effectiveness in the general population, patients with severe deficiencies in their immune defenses may be susceptible to side effects from the vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 4, 2016 Category: Global & Universal Source Type: news

Factor Lifestyle Into Immunodeficiency Treatment Choice Factor Lifestyle Into Immunodeficiency Treatment Choice
Patients with primary immunodeficiency disease should be asked about their lives, family, and work before a treatment regimen is chosen, and the discussion should be revisited as circumstances change.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2016 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

FDA OKs Immune Globulin Cuvitru for Primary Immunodeficiency FDA OKs Immune Globulin Cuvitru for Primary Immunodeficiency
Approval of immune globulin subcutaneous 20% solution follows positive data on efficacy and safety, as well as infusion time and number of injections sites.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2016 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news

Shire Announces FDA Approval of Cuvitru [immune globulin subcutaneous (human)] for Primary Immunodeficiency
Lexington, Mass. – September 14, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the United States Food and Drug Administration (FDA) has granted approval for Cuvitru [Immune Globulin Subcutaneous (Human), 20% Solution] in adult and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 14, 2016 Category: Drugs & Pharmacology Source Type: news

Primary Immunodeficiency Disease (PIDD)
Title: Primary Immunodeficiency Disease (PIDD)Category: Diseases and ConditionsCreated: 8/1/2016 12:00:00 AMLast Editorial Review: 8/1/2016 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - August 1, 2016 Category: Pediatrics Source Type: news